UroGen Pharma Ltd. (URGN)
NASDAQ: URGN
· Real-Time Price · USD
19.71
0.00 (0.00%)
At close: Aug 18, 2025, 2:54 PM
UroGen Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -154.97M | -138.43M | -126.87M | -115.38M | -113.58M | -104.32M | -102.24M | -105.1M | -109.05M | -111.6M | -109.78M | -109.37M | -113.75M | -113.28M | -110.82M | -112.89M | -111.5M | -116.63M |
Depreciation & Amortization | 1.67M | 1.33M | 1.19M | 1.3M | 1.45M | 1.62M | 1.71M | 1.73M | 1.75M | 1.8M | 1.82M | 1.82M | 1.83M | 1.8M | 1.77M | 1.94M | 1.98M | 2.02M |
Stock-Based Compensation | 12.59M | 13.42M | 13.11M | 12.42M | 11.15M | 9.81M | 9.34M | 9.1M | 9.32M | 9.92M | 10.58M | 13.57M | 16.64M | 19.87M | 23.11M | 24.28M | 25.53M | 26.6M |
Other Working Capital | 3.71M | 8.65K | 2.44M | 2.93M | 1.07M | 1.96M | 2.25M | -4.37M | -4.35M | -6.83M | -5.24M | -5.56M | -6.63M | -3.24M | -7.57M | -1.93M | 333K | -2.28M |
Other Non-Cash Items | 8.55M | 10.28M | 10.89M | 13.69M | 12.53M | 9.62M | 11.09M | 7.01M | 10.79M | 14.72M | 16.13M | 3.77M | 5.77M | 3.56M | -1.18M | 7.29M | 885K | -1.58M |
Deferred Income Tax | n/a | n/a | n/a | -4.25M | -1.47M | 1.33M | 1.33M | 5.57M | 2.8M | n/a | n/a | 14.98M | 15.14M | 15.13M | 15.32M | 396K | 386K | 532K |
Change in Working Capital | 9.03M | 6.35M | 4.92M | -3.99M | 4.08M | -429.52K | 2.34M | -3.45M | -1.05M | -4.2M | -6.31M | -10.65M | -12.38M | -8.57M | -13.11M | -7.07M | -9.95M | -8.6M |
Operating Cash Flow | -123.13M | -107.06M | -96.77M | -96.2M | -85.84M | -82.36M | -76.44M | -85.13M | -85.44M | -89.37M | -87.56M | -85.88M | -86.74M | -81.49M | -84.89M | -86.06M | -92.67M | -97.65M |
Capital Expenditures | -396K | -339K | -295K | -233.54K | -237.54K | -168.54K | -191.54K | -151K | -204K | -252K | -254K | -443K | -484K | -490K | -752K | -722K | -1.19M | -1.41M |
Cash Acquisitions | n/a | n/a | n/a | 11.29M | 10.79M | 6.66M | 6.66M | -28.17M | 7.67M | 11.79M | 11.79M | 35.34M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -196.16M | -194.37M | -128.02M | -132.97M | -25.01M | -24.62M | -48.8M | -34.19M | -86.37M | -86.76M | -62.58M | -63.31M | -10.24M | -51.9M | -51.9M | -51.59M | -41.66M | -20.31M |
Sales Maturities Of Investments | 152.87M | 134.62M | 107.7M | 40.99M | 40.18M | 31.84M | 48.79M | 68.66M | 84.99M | 81.17M | 64.32M | 50.83M | 43.96M | 55.03M | 56.72M | 96.73M | 89.83M | 116.95M |
Other Investing Acitivies | n/a | n/a | n/a | -11.65M | -11.15M | -7.41M | -7.41M | 27.36M | -8.48M | -12.31M | 1.31M | -12.48M | 33.71M | 3.13M | 4.82M | 45.13M | 48.17M | 96.64M |
Investing Cash Flow | -43.69M | -60.09M | -20.61M | -92.58M | 14.57M | 6.29M | -953K | 33.5M | -2.4M | -6.27M | 1.06M | -12.92M | 33.23M | 2.64M | 4.07M | 44.41M | 46.98M | 95.24M |
Debt Repayment | n/a | n/a | n/a | 24.39M | n/a | n/a | n/a | 24.99M | 24.99M | 24.95M | 95.78M | 70.79M | 70.79M | 70.83M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15K | -67K | -67K | -67K | -52K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 175.84M | 194.62M | 194.62M | 19.4M | 67.91M | 49.28M | 49.95M | 49.91M | 2.29M | 2.11M | 1.35M | 941K | -328K | 72.23M | 72.32M | 72.43M | 72.66M | 16.44M |
Financial Cash Flow | 40.01M | 140M | 194.62M | 194.59M | 271.06M | 170.92M | 116.93M | 142.26M | 27.28M | 27.06M | 97.13M | 71.73M | 70.47M | 143.06M | 72.32M | 72.43M | 72.66M | 16.44M |
Net Cash Flow | -126.81M | -27.15M | 77.24M | 5.87M | 199.85M | 94.91M | 39.6M | 90.63M | -60.56M | -68.57M | 10.63M | -27.07M | 16.95M | 64.21M | -8.5M | 30.77M | 26.97M | 14.03M |
Free Cash Flow | -123.53M | -107.39M | -97.06M | -96.44M | -86.08M | -82.53M | -76.63M | -85.28M | -85.65M | -89.62M | -87.81M | -86.32M | -87.22M | -81.98M | -85.64M | -86.79M | -93.86M | -99.06M |